214 related articles for article (PubMed ID: 29131570)
1. Identification and Characterization of Dual Inhibitors of the USP25/28 Deubiquitinating Enzyme Subfamily.
Wrigley JD; Gavory G; Simpson I; Preston M; Plant H; Bradley J; Goeppert AU; Rozycka E; Davies G; Walsh J; Valentine A; McClelland K; Odrzywol KE; Renshaw J; Boros J; Tart J; Leach L; Nowak T; Ward RA; Harrison T; Andrews DM
ACS Chem Biol; 2017 Dec; 12(12):3113-3125. PubMed ID: 29131570
[TBL] [Abstract][Full Text] [Related]
2. Differential Oligomerization of the Deubiquitinases USP25 and USP28 Regulates Their Activities.
Sauer F; Klemm T; Kollampally RB; Tessmer I; Nair RK; Popov N; Kisker C
Mol Cell; 2019 May; 74(3):421-435.e10. PubMed ID: 30926243
[TBL] [Abstract][Full Text] [Related]
3. Computational approach to target USP28 for regulating Myc.
Chakravorty D; Ghosh A; Saha S
Comput Biol Chem; 2020 Apr; 85():107208. PubMed ID: 32028107
[TBL] [Abstract][Full Text] [Related]
4. USP28 and USP25 are downregulated by Vismodegib in vitro and in colorectal cancer cell lines.
Wang H; Meng Q; Ding Y; Xiong M; Zhu M; Yang Y; Su H; Gu L; Xu Y; Shi L; Zhou H; Zhang N
FEBS J; 2021 Feb; 288(4):1325-1342. PubMed ID: 32578360
[TBL] [Abstract][Full Text] [Related]
5. Distinct USP25 and USP28 Oligomerization States Regulate Deubiquitinating Activity.
Gersch M; Wagstaff JL; Toms AV; Graves B; Freund SMV; Komander D
Mol Cell; 2019 May; 74(3):436-451.e7. PubMed ID: 30926242
[TBL] [Abstract][Full Text] [Related]
6. Structure and function of the highly homologous deubiquitinases ubiquitin specific peptidase 25 and 28: Insights into their pathophysiological and therapeutic roles.
Zhou L; Qin B; Yassine DM; Luo M; Liu X; Wang F; Wang Y
Biochem Pharmacol; 2023 Jul; 213():115624. PubMed ID: 37245535
[TBL] [Abstract][Full Text] [Related]
7. Cellular Assays for Dynamic Quantification of Deubiquitinase Activity and Inhibition.
Moghadasi SA; Moraes SN; Harris RS
J Mol Biol; 2023 Dec; 435(23):168316. PubMed ID: 37858708
[TBL] [Abstract][Full Text] [Related]
8. Otilonium Bromide acts as a selective USP28 inhibitor and exhibits cytotoxic activity against multiple human cancer cell lines.
Xu Z; Wang H; Meng Q; Ding Y; Zhu M; Zhou H; Zhang N; Shi L
Biochem Pharmacol; 2023 Sep; 215():115746. PubMed ID: 37579857
[TBL] [Abstract][Full Text] [Related]
9. USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell Carcinoma.
Prieto-Garcia C; Tomašković I; Shah VJ; Dikic I; Diefenbacher M
Cells; 2021 Oct; 10(10):. PubMed ID: 34685632
[TBL] [Abstract][Full Text] [Related]
10. USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma.
Ruiz EJ; Pinto-Fernandez A; Turnbull AP; Lan L; Charlton TM; Scott HC; Damianou A; Vere G; Riising EM; Da Costa C; Krajewski WW; Guerin D; Kearns JD; Ioannidis S; Katz M; McKinnon C; O'Connell J; Moncaut N; Rosewell I; Nye E; Jones N; Heride C; Gersch M; Wu M; Dinsmore CJ; Hammonds TR; Kim S; Komander D; Urbe S; Clague MJ; Kessler BM; Behrens A
Elife; 2021 Oct; 10():. PubMed ID: 34636321
[TBL] [Abstract][Full Text] [Related]
11. Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme.
Reverdy C; Conrath S; Lopez R; Planquette C; Atmanene C; Collura V; Harpon J; Battaglia V; Vivat V; Sippl W; Colland F
Chem Biol; 2012 Apr; 19(4):467-77. PubMed ID: 22520753
[TBL] [Abstract][Full Text] [Related]
12. Deubiquitinases (DUBs) and DUB inhibitors: a patent review.
Farshi P; Deshmukh RR; Nwankwo JO; Arkwright RT; Cvek B; Liu J; Dou QP
Expert Opin Ther Pat; 2015; 25(10):1191-1208. PubMed ID: 26077642
[TBL] [Abstract][Full Text] [Related]
13. Characterization of alternatively spliced products and tissue-specific isoforms of USP28 and USP25.
Valero R; Bayés M; Francisca Sánchez-Font M; González-Angulo O; Gonzàlez-Duarte R; Marfany G
Genome Biol; 2001; 2(10):RESEARCH0043. PubMed ID: 11597335
[TBL] [Abstract][Full Text] [Related]
14. Structure-based discovery of potent USP28 inhibitors derived from Vismodegib.
Zhou D; Xu Z; Huang Y; Wang H; Zhu X; Zhang W; Song W; Gao T; Liu T; Wang M; Shi L; Zhang N; Xiong B
Eur J Med Chem; 2023 Jun; 254():115369. PubMed ID: 37075624
[TBL] [Abstract][Full Text] [Related]
15. The emerging role of deubiquitylating enzyme USP21 as a potential therapeutic target in cancer.
Shi ZY; Li CY; Chen RY; Shi JJ; Liu YJ; Lu JF; Yang GJ; Chen J
Bioorg Chem; 2024 Jun; 147():107400. PubMed ID: 38688196
[TBL] [Abstract][Full Text] [Related]
16. Small molecule inhibitors reveal allosteric regulation of USP14 via steric blockade.
Wang Y; Jiang Y; Ding S; Li J; Song N; Ren Y; Hong D; Wu C; Li B; Wang F; He W; Wang J; Mei Z
Cell Res; 2018 Dec; 28(12):1186-1194. PubMed ID: 30254335
[TBL] [Abstract][Full Text] [Related]
17. USP28 promotes tumorigenesis and cisplatin resistance by deubiquitinating MAST1 protein in cancer cells.
Karapurkar JK; Colaco JC; Suresh B; Tyagi A; Woo SH; Jo WJ; Ko N; Singh V; Hong SH; Oh SJ; Kim KS; Ramakrishna S
Cell Mol Life Sci; 2024 Mar; 81(1):145. PubMed ID: 38498222
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of deubiquitinases primes glioblastoma cells to apoptosis in vitro and in vivo.
Karpel-Massler G; Banu MA; Shu C; Halatsch ME; Westhoff MA; Bruce JN; Canoll P; Siegelin MD
Oncotarget; 2016 Mar; 7(11):12791-805. PubMed ID: 26872380
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for the bi-specificity of USP25 and USP28 inhibitors.
Patzke JV; Sauer F; Nair RK; Endres E; Proschak E; Hernandez-Olmos V; Sotriffer C; Kisker C
EMBO Rep; 2024 May; ():. PubMed ID: 38816515
[TBL] [Abstract][Full Text] [Related]
20. Diarylcarbonates are a new class of deubiquitinating enzyme inhibitor.
Long MJC; Lawson AP; Baggio R; Qian Y; Rozhansky L; Fasci D; El Oualid F; Weerapana E; Hedstrom L
Bioorg Med Chem Lett; 2019 Jan; 29(2):204-211. PubMed ID: 30528168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
